Certara, Inc. (CERT) vs SOPHiA GENETICS SA (SOPH)
Certara, Inc. and SOPHiA GENETICS SA are both Health Information Services companies. Certara, Inc. is the larger, with a market value of $1.4B against $703.2M — 1.9× the size. SOPHiA GENETICS SA grew revenue faster over the last twelve months: 23.7% against 6.89%. Certara, Inc. has the higher net margin (−16.3% vs −93.9%) and the higher return on invested capital (0.07% vs −196.5%). Across the 18 metrics below, Certara, Inc. leads on 13 and SOPHiA GENETICS SA on 5.
Valuation
Profitability
| Metric | CERT | SOPH | Health Information Services median |
|---|---|---|---|
| Gross margin | 61.48% | 66.63% | 63.38% |
| Operating margin | 0.29% | (85.55%) | (8.35%) |
| Net margin | (16.26%) | (93.86%) | (14.70%) |
| Free cash flow margin | 12.97% | (47.83%) | 0.58% |
| Return on equity | (6.72%) | (101.22%) | (6.82%) |
| Return on assets | (4.65%) | (43.02%) | (6.02%) |
| Return on invested capital | 0.07% | (196.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack